CIRM Directors to Take Position on Affordability, Accountability Measure
Directors of the California stem cell agency on March 4 will take their first public look at new legislation aimed at ensuring affordable access to therapies financed by taxpayers, including proposals to improve accountability and openness at the state research effort.
Also on the table at the meeting of the directors' Legislative Subcommittee is legisl…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.